Jesse T Yurgelon, DPM
Podiatry · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 059462 · El Camino Health. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yurgelon’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$130,407
Medicare paid this office $130,407 for 510 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 224 | $27,631 | $81 |
| Return visit (30+ min) | 119 | $17,836 | $109 |
| New patient visit (30+ min) | 194 | $17,742 | $91 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 17 | $9,525 | $134 |
| Short return visit (20+ min) | 25 | $4,250 | $59 |
See all 14 services
| Short return visit (20+ min) | 224 | $27,631 | $81 |
| Return visit (30+ min) | 119 | $17,836 | $109 |
| New patient visit (30+ min) | 194 | $17,742 | $91 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 17 | $9,525 | $134 |
| Short return visit (20+ min) | 25 | $4,250 | $59 |
| Removal of skin and tissue, 20.0 sq cm or less | 16 | $4,202 | $52 |
| Permanent removal fingernail or toenail | 20 | $3,899 | $134 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $2,374 | $132 |
| Removal of fingernails or toenails, 6 or more nails | 27 | $1,826 | $38 |
| New patient visit (30+ min) | 18 | $1,249 | $69 |
| Aspiration and/or injection of fluid from small joint | 21 | $1,223 | $53 |
| Injection into tendon or ligament | 15 | $786 | $52 |
| Short return visit | 12 | $618 | $52 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 42 | $48 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of nail tissue | 28 | More than 62% of doctors who do this |
| Removal of tissue | 287 | More than 94% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
510 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 19% · Women 57% · Also on Medicaid 12% · Health risk score 1.14. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 67% · Diabetes 28% · Chronic kidney disease 24% · Coronary heart disease 23% · Atrial fibrillation 20% · Heart failure 15% · Depression 15% · Cancer 14% · COPD 9% · Dementia 9% · Stroke 7%.
The office billed $628,924, Medicare allowed $174,385 and paid $130,407; for 1,419 services of 76 kinds; $106 of it was for drugs given in the office and $130,301 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 510 | 1,419 | 76 | 1.14 | $628,924 | $130,407 |
| 2023 | 410 | 1,129 | 77 | 1.27 | $476,550 | $108,364 |
| 2022 | 424 | 1,212 | 76 | 1.13 | $531,262 | $116,892 |
| 2021 | 341 | 951 | 76 | 1.33 | $399,450 | $96,639 |
| 2020 | 360 | 1,151 | 75 | 1.52 | $563,710 | $113,701 |
| 2019 | 475 | 1,249 | 76 | 1.32 | $487,120 | $110,822 |
| 2018 | 367 | 1,140 | 74 | 1.37 | $372,799 | $85,399 |
| 2017 | 278 | 930 | 75 | 1.48 | $304,093 | $72,881 |
| 2016 | 205 | 438 | 74 | 1.40 | $173,586 | $42,335 |
| 2015 | 39 | 72 | 72 | 1.83 | $42,911 | $10,198 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Short return visit (20+ min) | 208 | $24,219 | $80 |
| New patient visit (30+ min) | 149 | $14,169 | $95 |
| Return visit (30+ min) | 88 | $13,788 | $116 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 11 | $5,346 | $137 |
| Permanent removal fingernail or toenail | 22 | $4,320 | $154 |
| Short return visit (20+ min) | 24 | $3,660 | $59 |
| Removal of skin and tissue, 20.0 sq cm or less | 22 | $2,923 | $51 |
| Injection into tendon or ligament | 15 | $1,318 | $53 |
| Removal of fingernails or toenails, 6 or more nails | 18 | $1,123 | $42 |
| New patient visit (30+ min) | 15 | $1,060 | $71 |
| Short return visit | 15 | $614 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 29 | $38 | None |
2022: 11 services
| Short return visit (20+ min) | 159 | $18,413 | $79 |
| New patient visit (30+ min) | 178 | $17,156 | $96 |
| Return visit (30+ min) | 98 | $16,669 | $114 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 16 | $8,267 | $138 |
| Short return visit (20+ min) | 26 | $5,690 | $61 |
| Removal of skin and tissue, 20.0 sq cm or less | 22 | $5,122 | $54 |
| Permanent removal fingernail or toenail | 13 | $2,496 | $166 |
| Removal of fingernails or toenails, 6 or more nails | 32 | $1,973 | $42 |
| Short return visit | 20 | $1,235 | $54 |
| Injection into tendon or ligament | 11 | $595 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 25 | $40 | None |
2021: 9 services
| Short return visit (20+ min) | 131 | $17,161 | $82 |
| Return visit (30+ min) | 80 | $13,746 | $122 |
| New patient visit (30+ min) | 121 | $11,497 | $95 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 15 | $6,523 | $139 |
| Short return visit (20+ min) | 30 | $4,108 | $58 |
| Removal of skin and tissue, 20.0 sq cm or less | 20 | $2,906 | $56 |
| Removal of fingernails or toenails, 6 or more nails | 31 | $2,219 | $44 |
| Permanent removal fingernail or toenail | 12 | $2,216 | $148 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $29 | None |
2020: 12 services
| Short return visit (20+ min) | 145 | $14,035 | $64 |
| New patient visit (30+ min) | 132 | $12,288 | $93 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 16 | $12,159 | $143 |
| Removal of skin and tissue, 20.0 sq cm or less | 27 | $8,456 | $56 |
| Return visit (30+ min) | 64 | $7,409 | $90 |
| Short return visit (20+ min) | 32 | $3,636 | $46 |
| Permanent removal fingernail or toenail | 18 | $3,248 | $141 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $2,261 | $126 |
| Removal of fingernails or toenails, 6 or more nails | 36 | $2,159 | $39 |
| Short return visit | 15 | $736 | $41 |
| New patient visit (15+ min) | 11 | $701 | $64 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $21 | None |
2019: 14 services
| New patient visit (30+ min) | 203 | $18,521 | $91 |
| Short return visit (20+ min) | 175 | $17,807 | $67 |
| Removal of skin and tissue, 20.0 sq cm or less | 33 | $6,751 | $52 |
| Return visit (30+ min) | 60 | $6,558 | $99 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 11 | $3,675 | $88 |
| Removal of fingernails or toenails, 6 or more nails | 51 | $3,378 | $38 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $2,689 | $117 |
| New patient visit (15+ min) | 29 | $1,964 | $68 |
| Short return visit (20+ min) | 26 | $1,818 | $41 |
| Permanent removal fingernail or toenail | 12 | $1,799 | $150 |
| Short return visit | 27 | $1,453 | $42 |
| New patient visit (30+ min) | 12 | $826 | $69 |
| Injection into tendon or ligament | 11 | $746 | $50 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $35 | None |
2018: 15 services
| New patient visit (30+ min) | 188 | $15,658 | $83 |
| Short return visit (20+ min) | 135 | $14,634 | $64 |
| Short return visit (20+ min) | 30 | $6,682 | $44 |
| Removal of skin and tissue, 20.0 sq cm or less | 24 | $6,487 | $56 |
| Return visit (30+ min) | 42 | $4,192 | $89 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 11 | $3,361 | $86 |
| Removal of fingernails or toenails, 6 or more nails | 47 | $3,154 | $38 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $2,500 | $114 |
| Permanent removal fingernail or toenail | 12 | $1,891 | $145 |
| Simple separation of fingernail or toenail from nail bed, first nail | 14 | $1,498 | $100 |
| Aspiration and/or injection of fluid from small joint | 14 | $817 | $45 |
| Removal of noncancer thickened skin growth, 1 growth | 16 | $786 | $49 |
| Injection into tendon or ligament | 11 | $617 | $47 |
| Removal of fingernails or toenails, 1-5 nails | 12 | $461 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $48 | None |
2017: 10 services
| New patient visit (30+ min) | 160 | $14,289 | $89 |
| Short return visit (20+ min) | 99 | $10,731 | $66 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 19 | $6,918 | $85 |
| Short return visit (20+ min) | 23 | $4,518 | $45 |
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $4,015 | $54 |
| Return visit (30+ min) | 32 | $3,366 | $96 |
| Removal of fingernails or toenails, 6 or more nails | 32 | $2,395 | $41 |
| Return visit (30+ min) | 11 | $731 | $66 |
| Short return visit | 12 | $409 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $36 | None |
2016: 4 services
| New patient visit (30+ min) | 67 | $6,560 | $98 |
| Short return visit (20+ min) | 63 | $6,161 | $66 |
| Return visit (30+ min) | 24 | $2,339 | $94 |
| Removal of fingernails or toenails, 6 or more nails | 30 | $1,507 | $42 |
Medicaid work
$559 in 2021
Medicaid paid $559 for 14 billed services this clinician did in 2021, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 14 | $559 |
| 2021 | 14 | 1 | 12 | $559 |
Drugs they prescribed that Part D paid
$8,878
Pharmacies billed $8,878 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 9% of their Part D prescriptions (21 of 237) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
233 generic and fewer than 11 brand-name prescriptions · $8,878 in drug cost · 39 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Econazole Nitrate | 23 | $2,372 | $103 |
| Ciclopirox | 40 | $1,181 | $30 |
| Fluorouracil | 12 | $641 | $53 |
| Diclofenac | 14 | $381 | $27 |
| Gabapentin | 14 | $364 | $26 |
See all 11 drugs
| Econazole Nitrate | 23 | $2,372 | $103 |
| Ciclopirox | 40 | $1,181 | $30 |
| Fluorouracil | 12 | $641 | $53 |
| Diclofenac | 14 | $381 | $27 |
| Gabapentin | 14 | $364 | $26 |
| Cephalexin | 19 | $153 | $8 |
| Terbinafine | 16 | $142 | $9 |
| Amoxicillin-Clavulanate Potass | 14 | $102 | $7 |
| Hydrocodone-Acetaminophen | 16 | $95 | $6 |
| Ibuprofen | 13 | $59 | $5 |
| Meloxicam | 16 | $33 | $2 |
Year by year
| 2024 | 237 | 103 | 9% (21) | None | $8,878 |
| 2023 | 227 | 111 | None | 6% | $16,134 |
| 2022 | 153 | 76 | 12% (18) | None | $8,865 |
| 2021 | 132 | 67 | 8% (11) | None | $7,515 |
| 2020 | 177 | 76 | 10% (17) | None | $4,080 |
| 2019 | 106 | 58 | 21% (22) | None | $3,919 |
| 2018 | 78 | 42 | 17% (13) | None | $1,604 |
| 2017 | 81 | 33 | 16% (13) | None | $1,244 |
| 2016 | 53 | 33 | 43% (23) | 0% | $1,608 |
| 2015 | 13 | 11 | None | None | $918 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Ciclopirox | 40 | $1,659 | $41 |
| Diclofenac | 23 | $1,355 | $59 |
| Econazole Nitrate | 12 | $699 | $58 |
| Terbinafine | 30 | $503 | $17 |
| Cephalexin | 18 | $244 | $14 |
| Amoxicillin-Clavulanate Potass | 15 | $190 | $13 |
| Ibuprofen | 12 | $186 | $15 |
| Meloxicam | 12 | $70 | $6 |
2022: 4 drugs
| Ciclopirox | 39 | $2,005 | $51 |
| Econazole Nitrate | 12 | $1,895 | $158 |
| Terbinafine | 17 | $330 | $19 |
| Hydrocodone-Acetaminophen | 13 | $89 | $7 |
2021: 3 drugs
| Ciclopirox | 25 | $688 | $28 |
| Meloxicam | 20 | $144 | $7 |
| Cephalexin | 12 | $137 | $11 |
2020: 7 drugs
| Diclofenac | 17 | $407 | $24 |
| Doxycycline Hyclate | 16 | $353 | $22 |
| Ciclopirox | 14 | $299 | $21 |
| Hydrocodone-Acetaminophen | 15 | $117 | $8 |
| Cephalexin | 15 | $85 | $6 |
| Meloxicam | 14 | $66 | $5 |
| Amoxicillin | 13 | $30 | $2 |
2019: 4 drugs
| Diclofenac | 21 | $631 | $30 |
| Terbinafine | 11 | $216 | $20 |
| Hydrocodone-Acetaminophen | 19 | $185 | $10 |
| Meloxicam | 14 | $49 | $3 |
2018: 3 drugs
| Cephalexin | 16 | $173 | $11 |
| Hydrocodone-Acetaminophen | 11 | $123 | $11 |
| Meloxicam | 14 | $73 | $5 |
2017: 2 drugs
| Cephalexin | 14 | $161 | $12 |
| Doxycycline Hyclate | 12 | $74 | $6 |
2016: 2 drugs
| Oxycodone-Acetaminophen | 12 | $201 | $17 |
| Hydrocodone-Acetaminophen | 11 | $139 | $13 |
Money from drug and device companies
$170 in 2025
| 2025 | 4 | 6 | None | $170 |
| 2024 | 4 | 5 | None | $578 |
| 2023 | 4 | 7 | None | $319 |
| 2022 | 2 | 5 | None | $2,484 |
| 2021 | 3 | 4 | $4,000 | $4,273 |
| 2020 | 6 | 23 | None | $3,313 |
| 2019 | 6 | 33 | $10,025 | $13,009 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| MIMEDX Group | None | $62 | 2 payments
|
| Smith+Nephew | Collagenase Santyl | $48 | 2 payments
|
| Paragon 28 | Portfolio | $33 | 1 payment
|
| Stryker | Infinity Adaptis | $28 | 1 payment
|
See all 6 published payments
| Paragon 28 | Meals · 2025-08-26 | Portfolio | $33 |
| Smith+Nephew | Meals · 2025-08-21 | Collagenase Santyl | $18 |
| Stryker | Meals · 2025-07-23 | Infinity Adaptis | $28 |
| MIMEDX Group | Meals · 2025-04-24 | None | $40 |
| Smith+Nephew | Meals · 2025-04-18 | Collagenase Santyl | $30 |
| MIMEDX Group | Meals · 2025-03-14 | None | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $578
| Stryker | Augment Injectable | $496 | 2 payments
|
| Paragon 28 | Phantom Fibula Nail | $37 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $23 | 1 payment
|
| Organogenesis | None | $22 | 1 payment
|
2023: $319
| Evolution Surgical | None | $208 | 4 payments
|
| Paragon 28 | Bun-Yo-Matic | $77 | 1 payment
|
| ConvaTec | Innovamatrix Ac | $17 | 1 payment
|
| Stryker | Infinity Adaptis | $16 | 1 payment
|
2022: $2,484
| Evolution Surgical | None | $2,461 | 4 payments
|
| Stryker | Prostep | $24 | 1 payment
|
2021: $4,273
| Arthrex | None | $4,000 | 1 payment
|
| Evolution Surgical | None | $169 | 2 payments
|
| Nevro | Omnia | $104 | 1 payment
|
2020: $3,313
| Arthrex | Distal Extremities Implants Forefoot Plates & Screws Mtp | $1,576 | 12 payments
|
| Evolution Surgical | None | $1,282 | 5 payments
|
| Stryker | Infinity | $361 | 1 payment
|
| Wright Medical Technology | Infinity | $50 | 2 payments
|
| Smith+Nephew | Grafix Pl | $33 | 2 payments
|
| Paragon 28 | None | $12 | 1 payment
|
2019: $13,009
| Smith+Nephew | Grafix Prime | $7,343 | 18 payments
|
| Medline Industries | Dermatology and Wound Care | $5,392 | 10 payments
|
| Integra LifeSciences | Salto Talaris Total Ankle Prosthesis | $153 | 2 payments
|
| Osiris Therapeutics | Stravix | $77 | 1 payment
|
| Evolution Surgical | None | $32 | 1 payment
|
| Tactile Systems Technology | Flexitouch | $12 | 1 payment
|
Professional record
- NPI
- 1689931347
- Licence
- CA E5172
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213E00000X (213E00000X); Student in a training program (390200000X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2012-04-19
- NPI last updated
- 2015-10-08
This is when the NPI record was last certified, not a medical board exam.